Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: A multicenter, randomized, double-blind, placebo-controlled studyRuey J. Sung, S. Hardy, Labros A. Karagounis et al.|American Heart Journal|1995Cited by 121